Skip to main content
. 2016 Jun 14;7:234. doi: 10.3389/fimmu.2016.00234

Figure 1.

Figure 1

Schematic view of pathological pattern of inflammatory myopathies and proven degree of pathogenicity of specific autoantibodies relative to each IM subtypes. Bold: high risk of neoplasia, Italics: amyopathic DM. NAM, necrotizing autoimmune myopathy; DM, dermatomyositis; ARS, anti-t-rna synthetase syndrome; sIBM, sporadic inclusion-body myositis.